BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Computerized Thermal Imaging, Inc. (COIB.OB) Completes Installation Of TIP(TM) Suite At UNE Biomechanics Research Laboratory


5/31/2006 12:30:29 PM

OGDEN, Utah, May 30 /PRNewswire-FirstCall/ -- Computerized Thermal Imaging, Inc. (CTI) , today announced successful installation of a Thermal Imaging Processor (TIP(TM)) at the University of New England (UNE) in Portland, Maine. Researchers at the UNE Biomechanics Research Laboratory completed installation of the CTI TIP(TM) system and related training during April 2006, equipping UNE with valuable imaging and data collection capabilities. UNE announced the use of the TIP(TM) system for a Peripheral Nerve Injury study earlier this month viewable on UNE's website http://www.une.edu/ur/news/thermalimaging.asp

Onsite installation of the TIP(TM) system and related training were provided by CTI within two weeks of the original order, equipping UNE personnel with the education and tools needed to begin valuable and accurate data collection. "We are pleased with the performance and quality of data collected from the TIP(TM) system thus far. CTI continues to work closely with the UNE staff to ensure customer satisfaction and to contribute program success," commented a spokesman from CTI. "The continued and growing role digital infrared imaging plays in aiding medical advancement and is illustrated by UNE's Peripheral Nerve Injury study. The UNE study is one indication of the value of CTI's digital imaging technologies and experience," the spokesman continued.

Principal researcher, Dr. Nancy Quick, Director of UNE's Biomechanics Research Laboratory, has started collecting data using the TIP(TM) system to quantify changes in blood flow during physical therapy treatment of peripheral nerve injuries. "The CTI thermal imaging system provides an innovative and effective manner of examining physiological changes that occur during the application of various physical therapy techniques used to treat nerve injuries that would otherwise be very difficult to measure," explained Dr. Quick. "The Information gained from this work will provide a framework for enhancing outcomes in the treatment of these disorders and will help guide future research in this area." The UNE study is funded in part by a training grant through the National Institutes of Health National Center for Medical Rehabilitation Research -- National Capital Area Network Rehabilitation Research Network.

About Computerized Thermal Imaging, Inc.(TM)

Computerized Thermal Imaging Inc. is in business to improve the quality of life through the development and deployment of thermal Infrared imaging and associated technologies. While CTI's infrared technology offers multiple existing and potential applications, its primary focus is in medical and industrial applications. CTI markets two FDA-cleared pain management products -- the Thermal Imaging Processor (TIP)(TM) and an infrared light therapy device called the Photonic Stimulator.

For more information please contact Pam Bloedel at pbloedel@cti-net.com or sales@cti-net.com. Additionally CTI can be reached at 801-776-4700.

This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are subject to certain risks, trends and uncertainties that could cause actual results to differ materially from those projected. Among those risks, trends and uncertainties are CTI's ability to continue as a going concern given its current financial condition, CTI's pending application before the FDA seeking pre-market approval of CTI's BCS 2100 breast imaging system, and CTI's ability to raise additional capital to fund cash requirements for future operations. In particular, careful consideration should be given to cautionary statements made in the various reports CTI has filed with the Securities and Exchange Commission. CTI undertakes no duty to update or revise such forward-looking statements.

Computerized Thermal Imaging, Inc.

CONTACT: Pam Bloedel of Computerized Thermal Imaging, Inc.,+1-801-776-4700, pbloedel@cti-net.com or sales@cti-net.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES